Abstract:Obesity is often associated with reduced plasma insulin-like growth factor 1 (IGF-1) levels, oxidative stress, mitochondrial damage, and cardiac dysfunction. This study was designed to evaluate the impact of IGF-1 on high-fat diet–induced oxidative, myocardial, geometric, and mitochondrial responses. FVB and cardiomyocyte-specific IGF-1 overexpression transgenic mice were fed a low- (10%) or high-fat (45%) diet to induce obesity. High-fat diet feeding led to glucose intolerance, elevated plasma levels of leptin, interleukin 6, insulin, and triglyceride, as well as reduced circulating IGF-1 levels. Echocardiography revealed reduced fractional shortening, increased end-systolic and end-diastolic diameter, increased wall thickness, and cardiac hypertrophy in high-fat–fed FVB mice. High-fat diet promoted reactive oxygen species generation, apoptosis, protein and mitochondrial damage, reduced ATP content, cardiomyocyte cross-sectional area, contractile and intracellular Ca2+ dysregulation (including depressed peak shortening and maximal velocity of shortening/relengthening), prolonged duration of relengthening, and dampened intracellular Ca2+ rise and clearance. Western blot analysis revealed disrupted phosphorylation of insulin receptor and postreceptor signaling molecules insulin receptor substrate 1 (tyrosine/serine phosphorylation), Akt, glycogen synthase kinase 3&bgr;, forkhead transcriptional factors, and mammalian target of rapamycin, as well as downregulated expression of mitochondrial proteins peroxisome proliferator-activated receptor-&ggr; coactivator 1&agr; and uncoupling protein 2. Intriguingly, IGF-1 mitigated high-fat–diet feeding-induced alterations in reactive oxygen species, protein and mitochondrial damage, ATP content, apoptosis, myocardial contraction, intracellular Ca2+ handling, and insulin signaling but not whole body glucose intolerance and cardiac hypertrophy. Exogenous IGF-1 treatment also alleviated high-fat diet–induced cardiac dysfunction. Our data revealed that IGF-1 alleviates high-fat diet–induced cardiac dysfunction despite persistent cardiac remodeling, possibly because of preserved cell survival, mitochondrial function, and insulin signaling.

Prediabetic Insulin Resistance Is Not Permissive To The Development Of Cardiac Resistance To Insulin-Like Growth Factor I In Ventricular Myocytes

Attenuated Cardiac Contractile Responsiveness to Insulin-Like Growth Factor I in Ventricular Myocytes from Biobreeding Spontaneous Diabetic Rats

Transgenic Overexpression of Insulin-Like Growth Factor I Prevents Streptozotocin-Induced Cardiac Contractile Dysfunction and Beta-Adrenergic Response in Ventricular Myocytes

Insulin Resistance Induces Hyperleptinemia, Cardiac Contractile Dysfunction but Not Cardiac Leptin Resistance in Ventricular Myocytes

High Glucose Induces Cardiac Insulin-Like Growth Factor I Resistance in Ventricular Myocytes: Role of Akt and ERK Activation

IGF-I Attenuates Diabetes-Induced Cardiac Contractile Dysfunction in Ventricular Myocytes

Decreased Cardiac Sarcoplasmic Reticulum Ca2+-ATPase Activity Contributes to Cardiac Dysfunction in Streptozotocin-Induced Diabetic Rats

The Analysis of Ultrastructure and Gene Expression of Sarco/endoplasmic Reticulum Calcium Handling Proteins in Alloxan-Induced Diabetic Rat Myocardium.

Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats.

Sucrose-induced Cardiomyocyte Dysfunction is Both Preventable and Reversible with Clinically Relevant Treatments.

Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity

Inhibition of PI-3 Kinase/akt/mtor, but Not Calcineurin Signaling, Reverses Insulin-Like Growth Factor I-induced Protection Against Glucose Toxicity in Cardiomyocyte Contractile Function

Short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance.

Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes

Cell-Specific Effects of Insulin in a Murine Model of Restenosis Under Insulin-Sensitive and Insulin-Resistant Conditions

Insulin-Like Growth Factor 1 Alleviates High-Fat Diet-Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function.

Impaired Cardiac Function and IGF-I Response in Myocytes from Calmodulin-Diabetic Mice: Role of Akt and RhoA.

Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes

Abstract 486: Genetic Deletion of Akt2 and AMPK Accentuates Insulin Resistance-Induced Cardiac Contractile Anomalies

Cardiac-specific Overexpression of Insulin-Like Growth Factor 1 Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage.

Alpha 2-Heremans Schmid Glycoprotein, A Putative Inhibitor Of Tyrosine Kinase, Prevents Glucose Toxicity Associated With Cardiomyocyte Dysfunction